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Microbes and Infection turns 20Fig. 1. Microbes and Infection celebrates twenty years of
interactions.
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The journal Microbes and Infection is celebrating its vigintennial anniversary and has reunited for this
occasion two dozen reviews illustrating achievements of the past as well as future challenges in the field
of infectious diseases. From top-notch vaccine development strategies, to high-throughput powered
analysis of complex host-pathogen interactions, to innovative therapeutic designs, this issue covers the
entire spectrum of pathogens and areas of their confrontation with the host.
© 2018 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.1. Introduction
Twenty years ago, Microbes and Infection was created.
Twenty years - a decent amount of time measured by the stan-
dards of a Human life, a fraction of a wink in History. But in thepublications on host-pathogen
vier Masson SAS. All rights reserveshort history of the field of molecular biology, twenty years are
more than enough for major scientific breakthroughs, tragic epi-
sodes, large victories, and overthrown dogmas. At the occasion of
our twentieth anniversary, we have the honour to present a compi-
lation of awide variety of reviews, which offer a glimpse at the state
of the art in infectious diseases research. And yet - although they
depict the present, they also mirror important episodes of the
past two decades and foreshadow as well the trials to come.2. Troubled times
Truly, the last twenty years have been marked by several epi-
demics, nay the threat of a pandemic. Two highly infectious corona-
viruses (SARS and MERS) hit the headlines at about ten years'
intervals. At the same time, the media provided ample coverage
of seasonal influenza A virus outbreaks, such as H5N1, known as
“bird flu” and considered the world's largest current pandemic
threat around 2006, the 2009 “swine flu” pandemic caused by
H1N1, or the threatening features of H7N9 in 2013. Shortly after-
wards, the EBOLA virus (EBOV) went on a rampage in western Af-
rica, killing over 11,000 individuals and annihilating decades of
fragile economic progress. More recently, the Zika virus (ZIKV)
and its neurological complications reached Latin America in 2017
with a huge epidemic in Brazil.
Despite much scientific progress in our understanding of infec-
tious diseases, the threat emanating from (re-)emerging infectious
diseases has increased over the past 2 decades due to the combina-
tion of interrelated factors, many of them tainted by human respon-
sibility. Thus far, all candidates for pandemics are zoonoses, and the
current meat-heavy agro-alimentary industry contributes signifi-
cantly to the maintenance of animal reservoirs and an evolutionary
playground for many pathogens, while the close contact between
animals and humans facilitates the emergence of animal-to-
human transmission as well as the drive towards antibiotic resis-
tance. This trend is bound to continue, as food production needsd.
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favours transmission of microbial pathogens. Furthermore, climate
change is constantly broadening the geographic range of a variety
of arthropod vectors, and globalization not only shuttles men and
merchandise around the planet but also infectious agents. Lastly,
let's not forget the pathogens that resist all our attempts at eradica-
tion. Despite almost three decades of massive investment into
finding a cure and a vaccine for the human immunodeficiency virus
(HIV), the latter keeps being one step ahead, principally through
phenomenal mutation strategies, nicely summarized in this issue
by Nomaguchi et al. [1].
In the eternal arms race between host and microbe, prevention
is still better than cure. And when it comes to infectious diseases,
prevention equals vaccination. Consistent with this, several of our
anniversary reviews advocate for various promising strategies for
further vaccine development. They emphasize the advantages of
live attenuated vaccines, but also the importance to achieve an
equilibrium between adequate attenuation and sufficient residual
immunogenicity.
Yun Zhao and colleagues argue convincingly that lipopolysac-
charide (LPS) is the ideal knob for fine-tuning live attenuated vac-
cines for Gram-negative bacteria. The authors carefully review
how structural modifications of LPS improve immunogenicity and
reduce the virulence of various bacteria [2]. The soundness of the
strategy is incidentally exemplified by the review from Pascual
et al., who discuss one of the most common, yet often overlooked,
zoonotic diseases worldwide - brucellosis, whose agent is an expert
in avoiding immune detection through the poor immunogenicity of
lipid A, as well as the unusual LPS core structure [3].
With regards to viruses, Frantz et al. propose transforming the
Rolls Royce of live attenuated vaccines, the measles vaccine, into
a “plug-and-play” platform for the fast development of new poten-
tial vaccines, by grafting antigenic proteins from other viruses onto
the particularly accommodatingmeasles vaccine [4]. And as for par-
asites, Low et al. suggest taking advantage of a relatively-unknown
organelle: the apicoplast, the exclusive property of Apicomplexan
parasites such as Plasmodium. This specificity plus the prokaryotic
features of the plastid make it an interesting target for drugs. As
there is still no efficient vaccine against malaria, the authors recom-
mend that we turn our attention to the plastid. Interestingly, many
drugs affecting the apicoplast lead to a “delayed death” phenome-
non, where only the second generation of parasites die - theoreti-
cally, the ideal conditions for the development for a so-called
“suicide vaccine” [5].
3. Times of technology
The development of high throughput sequencing technologies
has radically changed the landscape of every field in the life sci-
ences. Microbiology might be the one that managed the greatest
thrust into the unknown since the dawn of metagenomics, when
thousands and thousands of previously inaccessible life forms
could be uncovered in a single sequencing run. Driven by the tech-
nological changes, the scientist's viewpoint drastically shifted from
the close-up of one element to the wide-angle covering simulta-
neously the entire system. The frenzy of the need to find the “big
picture” led to the conviction that the individual can only be under-
stood in the spatiotemporal context of its surroundings.
An excellent example is provided by H€acker, who relates what
happens when the complexity of the pathogen's world pounces
on the complexity of the host apoptosis system, leading to the
conclusion that there is no such simple thing as “apoptosis ininfection” [6]. And even when the complexity of the pathogen
world is narrowed down to “only” the influenza A virus (IAV),
things stay pretty convoluted, as Downey et al. point out in their re-
view. They emphasize the importance of using in vivomodels rather
than cell cultures because communication between pulmonary
macrophages and epithelial cells shape the kinetics of cell death
during infection, which are in turn crucial for regulating the anti-
viral responses [7]. This view is supported by Brizic et al., who
describe insights on the neurological damage caused by the human
cytomegalovirus (HCMV) gained from a mouse model [8]. But even
when down to one receptor, complexity has still the final say. In this
research paper in our collection of reviews, the group of Ojcius un-
ravels the versatile role of the mitochondrial NOD-like receptor
NLRX1 in the modulation of the NLRP3 inflammasome: it activates
the NLRP3 inflammasome upon infection by pathogens but can
dampen its effects in the presence of mere commensal pathogens
[9].
The “omics”-era also fuelled the rise of the host-pathogen inter-
actome and the study of the microbiome. Bhela and Rouse provide
us with a good illustration of the complex host-pathogen interde-
pendence by describing the intricate microRNA (miRNA) network
between the herpes simplex virus (HSV) and the human host cell
[10]. Other communication forms between host and invader were
only discovered recently and remain largely mysterious. Zamith-
Miranda et al. gathered the sparse knowledge available about the
intriguing fungal extracellular vesicles (EVs), which excel at modu-
lating the host immune system as they please, while integrating
stress and environmental signals [11].
Unravelling of the microbiome composition and its influence
over nearly every physiological function of the human organism
is among the most important and intriguing discoveries of the
recent past. Within this framework, Pienkowska and colleagues
have assembled here a comprehensive review of the current
knowledge concerning the microbial communities of the upper
and lower human respiratory tract, including the techniques under-
lying data generation and analysis, as well as their applications in
health and disease [12]. Moreover, Loeper et al. describe how the
imbalance of the female urogenital microbiome increases the risk
for sexually transmitted infections [13].
However, the notion of individuality did not get lost in the big
picture. Quite the contrary - the advent of single cell RNA-
sequencing added a new awareness of extreme complexity to the
entire system. This aspect is elegantly discussed by Weigel and
Dersch. Pathogens live in a constantly changing and mostly hostile
environment, where resourcefulness and rapid adaptation are core
requirements for survival. Hence, a mixed population is best suited
to face sudden challenges. For that matter, another profound
dogma change of the past decades has been the rehabilitation of
“junk DNA” and “noise” thanks to the discovery of a huge number
of long noncoding RNAs and pervasive transcription. Just as the
latter is now considered raw material for evolution and adaptation,
stochastic fluctuations in gene expression, exacerbated in turn by
slight differences in the microenvironment and feedback loops,
drive the emergence of subpopulations in a genetically identical
population and can be considered a virulence strategy [14].
Countless pathogens evade efficient prevention and treatment
mainly because they developed cunning strategies to evade the
host immune system, drawing on wits forged by millions of years
of co-evolution. The key to defeat them relies on a meticulous
observation of these escape and subversion techniques, in the
hope to spot a loophole. Major advances in in vivo observation tech-
niques have proven crucial to boost the field; thus, a substantial
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blows between host defences and aggressors.
Advanced shape-shifting abilities belong assuredly to the
arsenal of many pathogens. With this in mind, Tu and colleagues
describe the genetic and molecular events underlying tachyzoite
to bradyzoite interconversion of Toxoplasma gondii, crucial for
establishing a latent infection in tissue cysts [15]; while L€offler
and Ebel dedicate themselves to the hardships of the immune sys-
tem regarding the extraordinary plasticity of many fungi, capable to
transit between yeast cells and hyphae and thus very different sizes
and surface molecule patterns [16]. Complement-evading strate-
gies in turn can be a serious obstacle for vaccine development.
This is the case of Bordetella pertussis, the causative agent of whoop-
ing cough. Thiriard et al. describe in detail the multiple ways the
bacterium can subvert the different steps in complement activation
and how this impacts on vaccine efficiency [17].
CovR/S mutants, a hypervirulent update of group A streptococci
(GAS), target neutrophils, as reported by Langshaw et al. Conse-
quently, the authors underscore the soundness of developing
multi-component vaccines, targeting separate virulence mecha-
nisms in parallel [18].
The interplay between pathogens and disease states is a central
feature that needs to be considered for the development of realistic
treatment strategies. Infectious diseases threaten especially the
population of developing countries; thus, factors such as low cost,
easy transport and storage, and safe drug administration are
crucial. Nyirenda and colleagues draw attention to the fact that
the susceptibility to invasive nontyphoidal Salmonella infection
peaks in young children suffering from malaria and anaemia. Un-
derstanding how an already impaired immune system deals with
a supplementary aggressor is a major challenge for vaccine devel-
opment [19].4. Times of treatments
Treatment strategies have tremendously diversified in conjunc-
tion with the continuous discovery of novel host-pathogen interac-
tion networks. The findings have led to previously unimaginable
therapies, such as the faecal transplants to treat Clostridium difficile
infection.
Close observation of the different stages of pathogenesis is
pivotal for improved therapy, state Rajasagi and Rouse in their re-
view on herpes stromal keratitits (SK). The authors describe how
classical treatment strategies mainly based on anti-viral drugs
and corticosteroids could be enriched by lipid pre-resolving medi-
ators, anti-angiogenic agents or manipulation of microRNAs and
metabolism [20]. A similar logic underlies the review by Vernel-
Pauillac and Werts, who combine the latest insights into how Lep-
tospira interrogans escapes the immune system with the most
recent tactics for drug and vaccine development. Notably, the au-
thors explain how computational and statistical approaches as
well as the CRISPR/Cas9 technology could assist vaccine design
[21]. The team of Oliveiro reminds us that sometimes the foe can
become a friend, at least in bits and pieces. They make a good
case for the use of serine protease inhibitors containing a Kunitz
domain normally used by helminth parasites to dampen the host
immune system, but which could come in very handy when the
latter goes over the top [22]. In turn, Olds et al. plead for the revival
of an “ancient universal stress molecule” - abscisic acid (ABA). The
versatile stress signalling molecule in plants and animals seems
indeed to have many applications: being essential for T. gondii
growth and development, it might be a therapeutic target; in mam-
mals, the hormone has displayed beneficial properties in a widerange of processes, including glucose metabolism, stem cell prolif-
eration, tumorigenesis, inflammation and depression [23].
Finally, serendipity is sometimes the researcher's best friend.
The recent era of epigenetics has popularized the use of drugs influ-
encing the methylation or acetylation state of cells, especially for
cancer treatment. The team of Jiang reveals how the newanticancer
drug Chidamide, a selective histone deacetylation inhibitor, suc-
cessfully lures out the HIV-1 provirus from latency - one of HIV's
sneakiest features [24].
But enough of the teaser for now - we sincerely wish Microbes
and Infection a very happy birthday and best wishes to all our
readers and contributors on this auspicious occasion.
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